SKI Market

Indian Indices

Nifty

25,405.30 -48.10
(-0.19%)

Sensex

83,239.47 -170.22
( -0.20%)

Bank Nifty

56,791.95 -207.25
( -0.36%)

Nifty IT

38,854.30 -24.80
( -0.06%)

Global Indices

Nasdaq

44,498.76 -17.19
(-0.04%)

Dow Jones

6,247.07 28.06
(0.45%)

Hang Seng

39,705.85 -56.63
(-0.14%)

Nikkei 225

8,774.69 -10.64
(-0.12%)

Forex

USD-INR

85.59 -0.04
(-0.04%)

EUR-INR

100.92 0.38
(0.38%)

GBP-INR

117.62 0.20
(0.17%)

JPY-INR

0.60 0.00
(0.46%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

290.2218799

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

35.14

31840.72

EPS(TTM)

Face Value()

Div & Yield %

72.53

1.1

Back

Vishvprabha Ventures Ltd - Board Meeting Outcome for 1. Reappointment Of Rakhi Ashokkumar Barod For Second Term As Non Executive Independent Director For 5 Years W.E.F July 01 2025 And Penalty Levied By BSE

Jun 28,2025

Reappointment of Rakhi Ashokkumar Barod as Non Executive independent director for second term w.e.f July 01 2025 and Penalty levied by BSE as per Mail dated June 27 2025

25,405.30 -48.10 (-0.19%)

83,239.47 -170.22 ( -0.20%)

56,791.95 -207.25 ( -0.36%)

38,854.30 -24.80 ( -0.06%)

44,498.76 -17.19 (-0.04%)

6,247.07 28.06 (0.45%)

39,705.85 -56.63 (-0.14%)

8,774.69 -10.64 (-0.12%)

85.59 -0.04 (-0.04%)

100.92 0.38 (0.38%)

117.62 0.20 (0.17%)

0.60 0.00 (0.46%)